National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Send to Printer
NCI Drug Dictionary

zileuton
A synthetic derivative of hydroxyurea with antiasthmatic properties. The leukotriene inhibitor zileuton blocks 5-lipoxygenase, which catalyzes the formation of leukotrienes from arachidonic acid; causes bronchodilation; decreases bronchial mucous secretion and edema; and may prevent or decrease the symptoms of asthma. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

US brand name:Zyflo
Abbreviation:ZLT
Chemical structure names:
  • (+-)-N-Hydroxy-N-(1-benzo[b]thien-2-ylethyl)-urea
  • N-(1-Benzo[b]thien-2-ylethyl)-N-hydroxyurea

Previous:Zevalin, Zevalin, zibotentan, ziconotide, zidovudine
Next:zinc sulfate, Zinecard, zinostatin, Zipan, zirconium Zr 89 cetuximab